Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

Clinical trial NCT04610892 · COMPLETED

Trial details

NCT number: NCT04610892
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Heart Disease (CHD)

Start date: 2020-11-04
Primary completion: 2023-11-08
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.